Search

everythinglearnresearchcommunity

for

Search:↓

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Too much epidermal growth factor can cause hair loss.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Alopecia areata causes significant stigma and emotional distress, with many affected individuals not receiving adequate support or treatment.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Phototherapy effectively treats certain alopecia areata types, especially if started early.

Certain hair and scalp features indicate a worse outcome in alopecia areata.

Alopecia areata significantly affects mental health and quality of life, with many feeling stigma and few receiving adequate treatment.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.